Volume | 176 198 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,465 | Bas Haut |
|||||
Minimum Bas | 1,39 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Checkpoint Therapeutics Inc | CKPT | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,42 | 1,39 | 1,465 | 1,39 | 1,435 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
991 | 176 198 | US$ 1,41 | US$ 248 976 | - | 1,30 - 3,62 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:00:05 | 10 | US$ 1,45 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
32,7M | 23,53M | - | 103k | -51,85M | -2,20 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Checkpoint Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
02/3/2024 | 02:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/2/2024 | 23:00 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
03/2/2024 | 02:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
02/2/2024 | 23:15 | Edgar (US Regulatory) | Form 8-K - Current report |
30/1/2024 | 23:10 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
30/1/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
05/1/2024 | 23:01 | Edgar (US Regulatory) | Form 8-K - Current report |
18/12/2023 | 13:10 | Edgar (US Regulatory) | Form 8-K - Current report |
17/11/2023 | 23:02 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
17/11/2023 | 23:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
13/11/2023 | 23:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/11/2023 | 23:10 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Checkpoint Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Checkpoint Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,43 | 1,53 | 1,39 | 1,43 | 317 186 | -0,04 | -2,80% |
1 mois | 2,00 | 2,01 | 1,39 | 1,64 | 360 760 | -0,61 | -30,50% |
3 mois | 1,86 | 2,355 | 1,39 | 1,91 | 407 702 | -0,47 | -25,27% |
6 mois | 2,00 | 3,62 | 1,36 | 2,12 | 657 468 | -0,61 | -30,50% |
1 an | 3,30 | 3,62 | 1,30 | 2,18 | 454 454 | -1,91 | -57,88% |
3 ans | 29,60 | 46,40 | 1,30 | 18,13 | 645 000 | -28,21 | -95,30% |
5 ans | 37,00 | 53,762 | 1,30 | 22,22 | 611 997 | -35,61 | -96,24% |